Axbio and TowerJazz Announces Successful Development of In-Vitro Diagnostic Bio-CMOS IC using its Advanced 300mm 65nm RFCMOS Platformd!

March 23, 2020

Breakthrough device planned to be inproduction by mid 2019, offering frontier solution for the medical market